Riskpilot← Back to searchSign inGet full accessArtroFocus AB
ABActiveOrg 5569416208Liljestigen 7Medical specialists activities · NACE 8622Est. 20132 employees
Revenue 2024
SEK 5,9M
+82% vs 2023
EBITDA margin
49.8%
+314% vs 2023
Equity ratio
63.8%
Financial strength
Net profit 2024
SEK 1,5M
-73% vs 2023
| Revenue | SEK 5,9M | +82% |
| EBITDA | SEK 2,9M | +314% |
| Net profit | SEK 1,5M | -73% |
| Total assets | SEK 13,3M | +5% |
| Equity | SEK 8,5M | +6% |
| Employees | 2 | — |
Legal name
ArtroFocus AB
Org number
5569416208
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
5 september 2013
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva hälso-och sjukvård, uthyrning av läkare samt förvalta, köpa och sälja värdepapper samt fastigheter och därmed förenlig verksamhet.
Address
Liljestigen 7
Phone
+4687788936
Email
lena.kivioja@artrofocus.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 796 | 2 787 | 2 872 | 3 226 | 5 870 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 616 | 2 042 | 2 070 | 707 | 2 925 |
| Depreciation & amort. | −18 | −10 | −15 | −15 | −24 |
| EBIT | 1 598 | 2 032 | 2 055 | 692 | 2 901 |
| Net financials | 118 | −1 451 | −2 817 | 4 402 | −1 336 |
| Profit before tax | 1 314 | 1 113 | 375 | 5 771 | 2 148 |
| Tax | −259 | −387 | −377 | −142 | −641 |
| Net profit | 1 055 | 726 | −2 | 5 629 | 1 507 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 195 | 6 124 | 6 353 | 12 641 | 13 303 |
| Equity | 2 461 | 2 787 | 2 584 | 8 013 | 8 483 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 459 | 870 | 1 034 | 1 664 | 1 608 |
| Total debt | 459 | 870 | 1 034 | 1 664 | 1 608 |
EBITDA margin
49.8%
This company
15.8%
Market median
+215% vs market
20202024
Equity ratio
63.8%
This company
38.2%
Market median
+67% vs market
20202024
Return on equity
17.8%
This company
18.4%
Market median
+3% vs market
20202024
Net profit margin
25.7%
This company
8.1%
Market median
+217% vs market
20202024
Asset turnover
0.44×
This company
1.12×
Market median
-61% vs market
20202024
Debt / equity
0.57×
This company
0.62×
Market median
+8% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CO | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ArtroFocus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Olov Håkan Werell | Audit | 0 companies |
| Jouko Erkki Kivioja | Board of Directors | 0 companies |
| Lena Carina Kivioja | Deputy Board Member | 0 companies |